Sign up USA
Proactive Investors - Run By Investors For Investors

Wall Street keeps steady eye on fiscal cliff developments

U.S. stocks were slightly down Friday morning as investors were waiting for a deal to be reached to avert the automatic tax hikes and spending cuts due to take effect in January. 
Wall Street keeps steady eye on fiscal cliff developments

U.S. stocks were slightly down Friday morning as investors were waiting for a deal to be reached to avert the automatic tax hikes and spending cuts due to take effect in January. 

The Dow was lately off a slight 3 points to 13,168, the Nasdaq was down 15 points to 2,977, and the S&P was lower by 3 points to 1,416. 

President Barack Obama and House Speaker John Boehner had another meeting yesterday on budget negotiations, with both offices reporting lines of communication remained open. 

Investors are anxious about Congress coming to an agreement to avert the so called fiscal cliff. U.S. House Speaker John Boehner said Wednesday that President Barack Obama’s plan can’t pass the House or Senate and there are some "serious differences” on the fiscal cliff.

It is feared that failure to come to an agreement would trigger a recession.

Markets largely ignored economic data on Friday in favour of keeping an eye on developments relating to budget negotiations. 

The Labour Department reported today that the cost of living fell last month by 0.3%, slightly higher than the expected 0.2% decline forecast by economists.  This followed a 0.1% increase the month before. 

Excluding food and energy, the CPI rose 0.1%, following a boost of 0.2% in October. The median market forecast was for a 0.2% rise.

Earlier this week, the Federal Reserve replaced the Operation Twist program that was due to expire at the end of the year, with a fresh round of Treasury purchases that will boost its balance sheet in an ongoing effort to reduce the jobless rate and bolster economic growth.

The Fed also established numerical thresholds for policy, and said it would likely keep rates near zero for as long as the unemployment rate remains above 6.5% and inflation is not forecast to rise above 2.5%. 

Another economic report today said U.S. industrial production rose 1.1% in November as manufacturing picked up after Hurricane Sandy.

Meanwhile, the first half of December has so far been good for the nation's manufacturers based on the PMI flash index, which rose to 54.2, up a solid 1.4 points from the final index for November. A reading over 50 indicates monthly growth in business activity.

In China, data showed stronger-than-expected growth in the manufacturing sector this month. The December preliminary reading of 50.9 for the HSBC purchasing managers' index topped the 50.8 expectation and was an improvement from the 50.5 reading in the preceding month. 

In corporate news today, Adobe Systems (NASDAQ:ADBE) saw its shares rise early Friday, after it posted fiscal fourth-quarter earnings that came in ahead of analyst expectations after the bell yesterday. Shares in the software company rose over 5.6%. 

Schlumberger (NYSE:SLB) warned Friday that that its fourth quarter earnings would take a hit due to continued contractual delays in some regions and weaker than expected activity in North America - news that is expected to weigh down the oil services sector today. 

Shares in the oil services company were lately down more than 5.7%. 

Healthcare insurer Centene Corp. (NYSE:CNC) also saw its shares fall over nine per cent Friday, after it slashed its full-year earnings guidance for 2012, citing higher medical costs.

In M&A news, cable TV company Discovery Communications (NASDAQ:DISCA) Friday said it was buying 12 TV networks in Norway, Sweden, Denmark and Finland in a deal worth around $1.7 billion.

Dutch paints and chemicals group Akzo Nobel Friday said it has sold its Decorative Paints business to rival PPG Industries (NYSE:PPG) for $1.05 billion. The sale is the latest move by the world's biggest paints maker to address problems it inherited through its $13 billion acquisition of the U.K.'s Imperial Chemical Industries in 2008.

Last year, AkzoNobel's North American decorative paints unit had revenue of $1.5 billion, about 7 per cent of the group total.

In the biotech sector, Isis Pharmaceuticals (NASDAQ:ISIS) and partner Genzyme, Friday said that the European Medicines Agency (EMA) turned down a marketing authorization application for their blood pressure drug, citing safety concerns.

Elsewhere on the Nasdaq, Apple (NASDAQ:AAPL) was also in focus as the company is debuting its iPhone 5 in China today, a move that is expected to help reverse the slide in its market share in that country. Shares in the iPhone and iPad maker were lately down by more than 3.9%. 


January crude advanced on the better-than-expected China data, rising 75 cents to $86.65 per barrel, while gold for February delivery rose $1 to $1,698 an ounce. 


European markets were lately mixed. The DAX was higher by 0.16%, while the CAC 40 led the FTSE 100 lower. They were down 0.05% and 0.03%, respectively.

View full PROAC profile View Profile

Proactiveinvestors Timeline

Related Articles

mobile phone
January 22 2018
Tremor is already in profit a year ahead of expectations and is a blueprint for similar acquisitions in the future.
April 16 2018
Global pharmaceutical R&D is forecast to reach $182bn by 2022 having grown at near 4% annually since 2006
November 15 2017
Next Fifteen Communications expects another strong performance in the second half

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use